Cargando…
Closing the gap, or the beauty of alleviating our patients' symptoms
Autores principales: | Petutschnigg, Johannes, Edelmann, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796706/ https://www.ncbi.nlm.nih.gov/pubmed/35717602 http://dx.doi.org/10.1002/ejhf.2585 |
Ejemplares similares
-
Osteopontin predicts clinical outcome in patients after treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI)
por: Lutz, Matthias, et al.
Publicado: (2017) -
Risk prediction in patients with low-flow, low-gradient aortic stenosis and reduced ejection fraction undergoing TAVI
por: Ludwig, Sebastian, et al.
Publicado: (2022) -
Management of patients with severe aortic stenosis in the TAVI-era: how recent recommendations are translated into clinical practice
por: Lauten, Alexander, et al.
Publicado: (2021) -
Quadricuspid Aortic Valve With Guarded Left Coronary Artery Ostium in an Infant With Myocardial Infarction
por: Tedga, Anne Aurelie, et al.
Publicado: (2022) -
Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry
por: Frank, Derk, et al.
Publicado: (2019)